REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This report examines the global market for materials and devices used in the delivery of aesthetic treatments.
The key objective is to present a comprehensive analysis of the medical aesthetic devices market for its five largest sectors and to forecast the direction of the global market through 2015.
REASONS FOR DOING THE STUDY
Recent U.S. Food and Drug Administration (FDA) approvals have expanded the number of medical aesthetic devices available in the U.S. These items have been available elsewhere in the world for many years, social stigmas or the absence of a middle class that can afford them has inhibited their adoption until now.
The expansion of the middle classes in developing economies, shifts in cultural outlooks for developed economies, and regulatory actions in the U.S. have led to a rapidly changing global market for medical aesthetic devices.
SCOPE OF REPORT
This report details the principles of operation, method of manufacture, regulatory restrictions, and current status of the global market for the following medical aesthetic devices:
- Botulinum neuromodulators for aesthetic applications
- Breast augmentation devices, including implants and injectable materials
- Injectable dermal fillers
- Devices for assisted liposuction using ultrasound, light, or water
- Externally-applied energy-emitting devices for:
- Permanent hair removal
- Ablative skin resurfacing
- Non-ablative skin resurfacing
- Treatment of vascular skin lesions
- Skin tightening
- Tattoo removal
- Acne treatment
- Treatment of pigmented skin lesions
- Cellulite reducti
The global market is also segmented geographically into the following regions:
- U.S
- Brazil
- China
- India
- Mexico
- Japan
- Europe
- Rest of the World
Trends in the markets are identified and used in conjunction with past market behavior to forecast future revenues and compounded annual growth rates (CAGRs) in current U.S. dollars from 2010 to 2015.
The regulatory environment for medical devices and drugs in the U.S. and Europe is described in detail, as it exerts a strong effect on the availability of the devices considered in this report. The properties and characteristics of human skin, hair, and breasts are discussed insofar as they affect device demand.
INTENDED AUDIENCE
This study will be of interest to persons in the medical device industry, their subcontractors, and their prospective investors; manufacturers of light sources and radiofrequency sources; producers of silicones and related chemicals; producers of the compounds and bacterial organisms necessary to produce dermal fillers and botulinum toxins; medical device importers; and physicians contemplating expansion of their practices to include aesthetic procedures.
METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used in preparing this study. BCC studied more than 50 companies to obtain market data. Industry insiders and FDA consultants were interviewed to obtain primary-source information. In addition, reviews were made of annual and quarterly reports, earnings call transcripts, websites, and press releases by device manufacturers; reports, studies, approval letters, and databases prepared or maintained by the FDA; medical journals and books on aesthetic procedure practices; statistics and press releases by medical societies; patent databases; physician websites; and demographic data maintained by governmental and non-governmental organizations.
ANALYST CREDENTIALS
J. Richard Rahn has worked in the medical device industry since 2000 and in the industrial instrumentation industry since 1997. He holds a Ph.D. in optical/ chemical physics. He is the author of several scientific publications and has been awarded eight U.S. patents as well as several foreign patents. He currently has several new patents pending.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at
www.bccresearch.com, enables readers to:
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The authors assume no responsibility for any loss or damage that might result from reliance on the reported information or its use.
